255 related articles for article (PubMed ID: 26090668)
21. The GAP portion of Pseudomonas aeruginosa type III secreted toxin ExoS upregulates total and surface levels of wild type CFTR.
Tukaye DN; Kwon SH; Guggino WB
Cell Physiol Biochem; 2013; 31(1):153-65. PubMed ID: 23428533
[TBL] [Abstract][Full Text] [Related]
22. Comparison of the exoS gene and protein expression in soil and clinical isolates of Pseudomonas aeruginosa.
Ferguson MW; Maxwell JA; Vincent TS; da Silva J; Olson JC
Infect Immun; 2001 Apr; 69(4):2198-210. PubMed ID: 11254575
[TBL] [Abstract][Full Text] [Related]
23. The ubiquitin ligase Cbl-b limits Pseudomonas aeruginosa exotoxin T-mediated virulence.
Balachandran P; Dragone L; Garrity-Ryan L; Lemus A; Weiss A; Engel J
J Clin Invest; 2007 Feb; 117(2):419-27. PubMed ID: 17235393
[TBL] [Abstract][Full Text] [Related]
24. Ezrin/radixin/moesin proteins are high affinity targets for ADP-ribosylation by Pseudomonas aeruginosa ExoS.
Maresso AW; Baldwin MR; Barbieri JT
J Biol Chem; 2004 Sep; 279(37):38402-8. PubMed ID: 15252013
[TBL] [Abstract][Full Text] [Related]
25. Pseudomonas aeruginosa ExoS ADP-ribosyltransferase inhibits ERM phosphorylation.
Maresso AW; Deng Q; Pereckas MS; Wakim BT; Barbieri JT
Cell Microbiol; 2007 Jan; 9(1):97-105. PubMed ID: 16889625
[TBL] [Abstract][Full Text] [Related]
26. Regulation of Rab5 function during phagocytosis of live Pseudomonas aeruginosa in macrophages.
Mustafi S; Rivero N; Olson JC; Stahl PD; Barbieri MA
Infect Immun; 2013 Jul; 81(7):2426-36. PubMed ID: 23630954
[TBL] [Abstract][Full Text] [Related]
27. Interactions between effector proteins of the Pseudomonas aeruginosa type III secretion system do not significantly affect several measures of disease severity in mammals.
Shaver CM; Hauser AR
Microbiology (Reading); 2006 Jan; 152(Pt 1):143-152. PubMed ID: 16385124
[TBL] [Abstract][Full Text] [Related]
28. Intracellular targeting of exoenzyme S of Pseudomonas aeruginosa via type III-dependent translocation induces phagocytosis resistance, cytotoxicity and disruption of actin microfilaments.
Frithz-Lindsten E; Du Y; Rosqvist R; Forsberg A
Mol Microbiol; 1997 Sep; 25(6):1125-39. PubMed ID: 9350868
[TBL] [Abstract][Full Text] [Related]
29. The pilT gene contributes to type III ExoS effector injection into epithelial cells in Pseudomonas aeruginosa.
Shikata M; Hayashi N; Fujimoto A; Nakamura T; Matsui N; Ishiyama A; Maekawa Y; Gotoh N
J Infect Chemother; 2016 Apr; 22(4):216-20. PubMed ID: 26809217
[TBL] [Abstract][Full Text] [Related]
30. The ADP-ribosylation domain of Pseudomonas aeruginosa ExoS is required for membrane bleb niche formation and bacterial survival within epithelial cells.
Angus AA; Evans DJ; Barbieri JT; Fleiszig SM
Infect Immun; 2010 Nov; 78(11):4500-10. PubMed ID: 20732998
[TBL] [Abstract][Full Text] [Related]
31. Pseudomonas aeruginosa Effector ExoS Inhibits ROS Production in Human Neutrophils.
Vareechon C; Zmina SE; Karmakar M; Pearlman E; Rietsch A
Cell Host Microbe; 2017 May; 21(5):611-618.e5. PubMed ID: 28494242
[TBL] [Abstract][Full Text] [Related]
32. ExoS and ExoT ADP ribosyltransferase activities mediate Pseudomonas aeruginosa keratitis by promoting neutrophil apoptosis and bacterial survival.
Sun Y; Karmakar M; Taylor PR; Rietsch A; Pearlman E
J Immunol; 2012 Feb; 188(4):1884-95. PubMed ID: 22250085
[TBL] [Abstract][Full Text] [Related]
33. Pseudomonas aeruginosa injects type III effector ExoS into epithelial cells through the function of type IV pili.
Hayashi N; Nishizawa H; Kitao S; Deguchi S; Nakamura T; Fujimoto A; Shikata M; Gotoh N
FEBS Lett; 2015 Apr; 589(8):890-6. PubMed ID: 25747138
[TBL] [Abstract][Full Text] [Related]
34. Activities of Pseudomonas aeruginosa effectors secreted by the Type III secretion system in vitro and during infection.
Lee VT; Smith RS; Tümmler B; Lory S
Infect Immun; 2005 Mar; 73(3):1695-705. PubMed ID: 15731070
[TBL] [Abstract][Full Text] [Related]
35. Degradation of interleukin 8 by the serine protease MucD of Pseudomonas aeruginosa.
Okuda J; Hayashi N; Tanabe S; Minagawa S; Gotoh N
J Infect Chemother; 2011 Dec; 17(6):782-92. PubMed ID: 21626303
[TBL] [Abstract][Full Text] [Related]
36. ADP-ribosylation and functional effects of Pseudomonas exoenzyme S on cellular RalA.
Fraylick JE; Riese MJ; Vincent TS; Barbieri JT; Olson JC
Biochemistry; 2002 Jul; 41(30):9680-7. PubMed ID: 12135390
[TBL] [Abstract][Full Text] [Related]
37. Molecular heterogeneity of a type III cytotoxin, Pseudomonas aeruginosa exoenzyme S.
Maresso AW; Riese MJ; Barbieri JT
Biochemistry; 2003 Dec; 42(48):14249-57. PubMed ID: 14640693
[TBL] [Abstract][Full Text] [Related]
38. Intracellular membrane localization of pseudomonas ExoS and Yersinia YopE in mammalian cells.
Krall R; Zhang Y; Barbieri JT
J Biol Chem; 2004 Jan; 279(4):2747-53. PubMed ID: 14597627
[TBL] [Abstract][Full Text] [Related]
39. The Pseudomonas aeruginosa Type III secretion system plays a dual role in the regulation of caspase-1 mediated IL-1beta maturation.
Galle M; Schotte P; Haegman M; Wullaert A; Yang HJ; Jin S; Beyaert R
J Cell Mol Med; 2008; 12(5A):1767-76. PubMed ID: 18081695
[TBL] [Abstract][Full Text] [Related]
40. Fms-Like Tyrosine Kinase-3 Ligand Attenuates Local and Systemic Infection in a Model of Post-Burn Pneumonia.
Hundeshagen G; Cui W; Musgrove L; Cherry A; Lee SJ; Cox RA; Toliver-Kinsky T
Shock; 2018 Jun; 49(6):721-727. PubMed ID: 28796661
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
